Navigation Links
HCM Announces Substantial Growth in 2007
Date:2/26/2008

Attracts new talent to key positions

BURLINGTON, Mass., Feb. 26 /PRNewswire/ -- Hyaluron Contract Manufacturing (HCM), a leading provider of pharmaceutical development services, continued to expand its business in 2007 with revenues increasing greater than 75 percent and staffing increasing greater than 60 percent to support past and anticipated future growth. Additionally, HCM acquired additional space at its Burlington MA facility to expand its analytical chemistry, microbiology and engineering laboratories as well as to provide additional manufacturing capacity.

"We are very proud of our recent growth," Shawn Kinney, president of HCM states. "It's a reflection of our ongoing commitment to continuous improvements and to providing high quality products and services to our customers."

HCM has continued to strengthen its management team with the appointment of Susan McNamara to the newly created position of Director of Quality and Christopher Paolillo to the position of Director of Contract Administration and Legal Affairs and other key hires.

Susan McNamara has over seventeen years of experience in the biotechnology industry, bringing novel recombinant proteins into clinical and commercial production. Before joining HCM, McNamara was Associate Director, QC Microbiology at Wyeth Biotech. Prior to that, McNamara was employed by Fisons Pharmaceuticals and SmithKline.

Christopher Paolillo has over twenty-seven years of experience as corporate counsel and as an attorney in private practice and with the office of Air Force Judge Advocate. He brings to HCM substantial experience in contracts, licensing, intellectual property, and commercial transactions. Prior to HCM, Paolillo was employed by ACI Worldwide (formerly P&H Solutions) as Vice President and Corporate Counsel.

Located in Burlington, MA, HCM has been offering aseptic formulation and filling services to biotechnology and pharmaceutical companies. At the core of HCM's business is a commitment to quality, regulatory compliance and on-time delivery.
For further information, visit http://www.hyaluron.com

Contact: Claudio Tracanna

Office Phone: 781-270-7900 x 114

Cell Phone: 781-443-2850

Email: ctracanna@hyaluron.com


'/>"/>
SOURCE Hyaluron, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. NPS Pharmaceuticals Announces Senior Management Changes
2. BSPs New Line of HyperQ Products: Bedside Ischemia Monitoring Systems Announces Successful Results of First Feasibility Study
3. Boston Scientific Announces Addition to Clinical Sciences Organization
4. Neurobiological Technologies Announces Amendment of License and Cooperation Agreement with Merz Pharmaceuticals and Childrens Hospital
5. ARIUS announces five abstracts selected for presentation at 2008 AACR Annual Meeting
6. ProMetic announces signature of definitive license agreement with Kedrion for two hyperimmune products
7. Microfluidic Systems Announces Agreements With Applied Biosystems and United Technologies Hamilton Sundstrand Division for Production of Bioagent Autonomous Networked Detector System
8. Human Genome Sciences Announces Fourth Quarter and Full Year 2007 Financial Results and Recent Progress
9. Idenix Announces Data Presentations at the 43rd Annual Meeting of the European Association for the Study of the Liver (EASL)
10. Aton Pharma Announces the Appointment of Dr. Fred Eshelman to Management Board
11. Strativa Pharmaceuticals, a Division of Par Pharmaceutical, Announces the Discontinuation of the Development Program for Pafuramidine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)...   EpiBiome , a precision microbiome engineering company, ... financing from Silicon Valley Bank (SVB). The financing will ... its drug development efforts, as well as purchase additional ... has been an incredible strategic partner to us – ... would provide," said Dr. Aeron Tynes Hammack , ...
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
(Date:6/23/2016)... ... 23, 2016 , ... ClinCapture, the only free validated electronic ... showcase its product’s latest features from June 26 to June 30, 2016 for ... Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug Information ...
(Date:6/23/2016)... , June 23, 2016 ... research report to its pharmaceuticals section with historic ... details and much more. Complete report ... 151 pages, profiling 15 companies and supported with ... http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . The Global ...
Breaking Biology Technology:
(Date:6/20/2016)... , June 20, 2016 Securus ... justice technology solutions for public safety, investigation, corrections ... the prisons involved, it has secured the final ... (DOC) facilities for Managed Access Systems (MAS) installed. ... additional facilities to be installed by October, 2016. ...
(Date:6/7/2016)... June 7, 2016  Syngrafii Inc. and San ... relationship that includes integrating Syngrafii,s patented LongPen™ eSignature ... This collaboration will result in greater convenience for ... union, while maintaining existing document workflow and compliance ... ...
(Date:6/1/2016)... , June 1, 2016 Favorable ... Election Administration and Criminal Identification to Boost Global Biometrics ... recently released TechSci Research report, " Global Biometrics Market ... Competition Forecast and Opportunities, 2011 - 2021", the global ... by 2021, on account of growing security concerns across ...
Breaking Biology News(10 mins):